+关注
小朋戈
暂无个人介绍
IP属地：广东
7
关注
0
粉丝
0
主题
0
勋章
主贴
热门
小朋戈
09-04 10:56
班
康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果
小朋戈
2025-12-19
＇。 ＇;
美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%
小朋戈
2025-12-17
抱歉，原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4113521397048440","uuid":"4113521397048440","gmtCreate":1650965099648,"gmtModify":1770553831599,"name":"小朋戈","pinyin":"xpgxiaopengge","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","hatId":"ca_profile_frame_Lm11L6","hatName":"","vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":5,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":603969722180896,"gmtCreate":1788490584676,"gmtModify":1788491314353,"author":{"id":"4113521397048440","authorId":"4113521397048440","name":"小朋戈","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4113521397048440","authorIdStr":"4113521397048440"},"themes":[],"title":"","htmlText":"班","listText":"班","text":"班","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603969722180896","repostId":"2664383605","repostType":2,"repost":{"id":"2664383605","kind":"news","pubTimestamp":1788487320,"share":"https://www.laohunote.com/m/news/2664383605?lang=zh_CN&edition=full","pubTime":"2026-09-04 10:02","market":"hk","language":"zh","title":"康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383605","media":"新浪港股","summary":"9月4日，$康方生物$盘中涨超8%。9月3日，康方生物宣布，依沃西单抗头对头对比$K$药一线治疗PD-L1阳性晚期非小细胞肺癌的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头对比PD-1/L1疗法的全球Ⅲ期临床中，取得OS和PFS双阳性结果，未来有望凭借更优疗效撬动既有市场格局。","content":"<html><head></head><body><p style=\"text-align: left;\">9月4日，<a href=\"https://laohu8.com/S/09926\">康方生物</a>盘中涨超8%。截至发稿，股价上涨8.04%，现报98.1港元，成交额15亿港元。</p><p style=\"text-align: left;\">此外，诺诚健华升逾2%，和黄医药、四环医药、翰森制药升近2%。</p><p style=\"text-align: left;\">9月3日，康方生物宣布，依沃西单抗头对头对比<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>药一线治疗PD-L1阳性（TPS≥1%）晚期非小细胞肺癌（NSCLC）的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头对比PD-1/L1疗法的全球Ⅲ期临床中，取得OS和PFS双阳性结果，未来有望凭借更优疗效撬动既有市场格局。</p><p style=\"text-align: left;\">公开资料显示，帕博利珠单抗是开启肿瘤免疫治疗1.0时代最具代表性的药物，推动了肺癌治疗的重大进步，成为全球商业化最成功的创新药物之一。在帕博利珠单抗的基础上，依沃西进一步让患者实现显著获益，展现了依沃西作为下一代肿瘤免疫基石药物的突破性临床价值和巨大商业化价值潜力。</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/09e454814ff665aeb70cdb70bfdecf5e\" data-align=\"center\" tg-width=\"973\" tg-height=\"602\"/><span></span></p></body></html>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-04 10:02 北京时间 <a href=https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4027860.shtml><strong>新浪港股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月4日，康方生物盘中涨超8%。截至发稿，股价上涨8.04%，现报98.1港元，成交额15亿港元。此外，诺诚健华升逾2%，和黄医药、四环医药、翰森制药升近2%。9月3日，康方生物宣布，依沃西单抗头对头对比K药一线治疗PD-L1阳性（TPS≥1%）晚期非小细胞肺癌（NSCLC）的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4027860.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{},"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4027860.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2664383605","content_text":"9月4日，康方生物盘中涨超8%。截至发稿，股价上涨8.04%，现报98.1港元，成交额15亿港元。此外，诺诚健华升逾2%，和黄医药、四环医药、翰森制药升近2%。9月3日，康方生物宣布，依沃西单抗头对头对比K药一线治疗PD-L1阳性（TPS≥1%）晚期非小细胞肺癌（NSCLC）的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头对比PD-1/L1疗法的全球Ⅲ期临床中，取得OS和PFS双阳性结果，未来有望凭借更优疗效撬动既有市场格局。公开资料显示，帕博利珠单抗是开启肿瘤免疫治疗1.0时代最具代表性的药物，推动了肺癌治疗的重大进步，成为全球商业化最成功的创新药物之一。在帕博利珠单抗的基础上，依沃西进一步让患者实现显著获益，展现了依沃西作为下一代肿瘤免疫基石药物的突破性临床价值和巨大商业化价值潜力。","news_type":1,"symbols_score_info":{"09926":2.1,"KURE":0.6}},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":512315641295704,"gmtCreate":1766104094017,"gmtModify":1766109461993,"author":{"id":"4113521397048440","authorId":"4113521397048440","name":"小朋戈","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4113521397048440","authorIdStr":"4113521397048440"},"themes":[],"title":"","htmlText":" ＇。 ＇; ","listText":" ＇。 ＇; ","text":"＇。 ＇;","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/512315641295704","repostId":"1191049562","repostType":2,"repost":{"id":"1191049562","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1766098908,"share":"https://www.laohunote.com/m/news/1191049562?lang=zh_CN&edition=full","pubTime":"2025-12-19 07:01","market":"us","language":"zh","title":"美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191049562","media":"老虎资讯综合","summary":"周四美股成交额第1名 $特斯拉 $ 收高3.45%，成交458.48亿美元。根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。第10名 $Palantir $ 收高4.74%，成交74.09亿美元。该股2025年迄今已累计上涨近100%。","content":"<html><head></head><body><p><strong>周四美股成交额第1名 </strong><a href=\"https://laohu8.com/S/TSLA\">特斯拉 </a> <strong>收高3.45%，成交458.48亿美元。</strong></p><p style=\"text-align: justify;\">据媒体周四报道，马斯克上周在xAI位于旧金山的总部召开的全体员工大会上表示，如果公司能够成功度过未来两到三年的关键发展期，xAI将最终在人工智能竞赛中击败所有竞争对手。</p><p style=\"text-align: justify;\"><strong>第2名 </strong><a href=\"https://laohu8.com/S/NVDA\">英伟达 </a> <strong>收高1.87%，成交304.13亿美元。</strong></p><p style=\"text-align: justify;\">英伟达与美国政府将通过“创世纪使命”计划加大人工智能基础设施建设和研发投入。该公司周四表示，已与美国能源部签署谅解备忘录，概述合作重点以支持加速科学发现。</p><p style=\"text-align: justify;\"><strong>第3名 </strong><a href=\"https://laohu8.com/S/AVGO\">博通 </a> <strong>收高1.18%，成交178.66亿美元。</strong></p><p style=\"text-align: justify;\">摩根大通预计，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升，这意味着明年将新增超过1500亿美元的增量支出，而华尔街预测尚未计入资本支出带来的AI收入上行空间。</p><p style=\"text-align: justify;\">根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。这意味着明年将新增超过1500亿美元的增量支出，基本覆盖英伟达、AMD、博通和Marvell等核心AI芯片厂商的预期营收。</p><p style=\"text-align: justify;\"><strong>第4名 </strong><a href=\"https://laohu8.com/S/MU\">美光科技 </a> <strong>收高10.21%，成交162.48亿美元。</strong></p><p style=\"text-align: justify;\">该公司的财报显示其存储芯片需求强劲，且远超市场预期。</p><p style=\"text-align: justify;\">在面向分析师的财报电话会议上，这家主营计算机及人工智能服务器存储产品的企业表示，数据中心的需求是推动其产品销量增长的核心动力。</p><p style=\"text-align: justify;\">美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。</p><p style=\"text-align: justify;\">“我们的产品早已全面售罄。”美光科技业务总裁苏米特-萨达纳表示，“目前订单需求缺口巨大，这种供不应求的局面，在可预见的未来还将持续。”</p><p style=\"text-align: justify;\">美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。</p><p style=\"text-align: justify;\"><strong>第7名</strong><a href=\"https://laohu8.com/S/META\">Meta Platforms </a> <strong>收高2.30%，成交128.51亿美元。</strong></p><p style=\"text-align: justify;\">昨日有报道称谷歌联手Meta推进TorchTPU计划挑战英伟达AI芯片地位。该报道称，谷歌推进“TorchTPU”计划，提升TPU运行PyTorch性能，欲削弱英伟达AI计算市场霸主地位，并与Meta合作以降低企业迁移成本。</p><p style=\"text-align: justify;\"><strong>第8名 </strong><a href=\"https://laohu8.com/S/AMZN\">亚马逊 </a> <strong>收高2.48%，成交109.64亿美元。</strong></p><p style=\"text-align: justify;\">据报道，该公司正洽谈向OpenAI投资超100亿美元，并提供Trainium芯片及AWS算力资源，此举或使OpenAI估值突破5000亿美元，并扩大亚马逊在生成式AI领域的布局。</p><p style=\"text-align: justify;\"><strong>第9名 </strong><a href=\"https://laohu8.com/S/GOOGL\">谷歌-A </a> <strong>收高1.93%，成交97.47亿美元。</strong></p><p style=\"text-align: justify;\">周四有报道称，与Alphabet旗下谷歌公司相关的某数据中心开发商正计划发行12.8亿美元、五年期的垃圾债券（高收益债），为项目进行部分融资。</p><p style=\"text-align: justify;\">据知情人士透露，该交易由摩根士丹利领投，债券的定价收益率预计在7.25%左右。此次发行背景是投资者对AI“淘金热”的财务根基愈发感到不安，因为这一领域的扩张很大程度上是依赖借贷驱动的。</p><p style=\"text-align: justify;\"><strong>第10名 </strong><a href=\"https://laohu8.com/S/PLTR\">Palantir </a> <strong>收高4.74%，成交74.09亿美元。</strong></p><p style=\"text-align: justify;\"><strong>第15名</strong><a href=\"https://laohu8.com/S/LLY\">礼来 </a> <strong>收高1.45%，成交40.85亿美元。</strong></p><p style=\"text-align: justify;\">该公司宣布，其口服减肥药orforglipron在一项三期临床试验中显示出优于对照的体重维持效果，适用于此前已使用注射型减肥药（包括公司自身的Zepbound以及诺和诺德（NVO.US）的Wegovy）的肥胖或超重成年人。</p><p style=\"text-align: justify;\">礼来援引ATTAIN-MAINTAIN试验的顶线数据称，在为期52周的研究中，从Wegovy或Zepbound转换为orforglipron的患者，基本维持了此前通过注射药物获得的减重成果。数据显示，与对照相比，从Wegovy转换的患者体重平均差异为0.9公斤，从Zepbound转换的患者体重平均差异为5.0公斤。</p><p style=\"text-align: justify;\"><strong>第18名 </strong><a href=\"https://laohu8.com/S/TSM\">台积电 </a> <strong>收高2.79%，成交32亿美元。</strong></p><p style=\"text-align: justify;\">台积电2nm的量产工作会在今年底正式启动，目前两座工厂的2nm产能已经被预订一空，台积电需要额外新建工厂来满足客户需求，这项工程预计需要286亿美元的投资。据悉，苹果、高通、联发科、AMD等多家企业都是台积电2nm工艺的客户，台积电难以满足所有客户的需求，目前苹果拿下了超半数的初始产能，剩下的产能则由其它客户瓜分。按照计划，台积电将在2026年底前把月产量提升至10万片。</p><p style=\"text-align: justify;\">摩根士丹利上调台积电目标股价。</p><p style=\"text-align: justify;\"><strong>第20名 </strong><a href=\"https://laohu8.com/S/GEV\">GE Vernova </a> <strong>收高4.11%，成交28.51亿美元。</strong></p><p style=\"text-align: justify;\">受益于AI数据中心板块反弹以及杰富瑞分析师将其评级上调至“买入”。</p><p style=\"text-align: justify;\">杰富瑞分析师在周四发布的一份研报中写道：“我们上调其构配件至买入。我们对电力业务（燃气定价及服务可见性）和电气化前景更加乐观，但自12月9日分析师日以来股价却出现下跌。目标价上调至815美元，此前为736美元。燃气轮机定价持续带来正面惊喜，服务业务为2030年代中后期提供了清晰的能见度，最终将抵消燃气设备业务的疲软。”</p><p style=\"text-align: justify;\">该目标价略高于FactSet统计的市场一致预期目标价753美元，较GE Vernova周三收盘价溢价约23%。该股2025年迄今已累计上涨近100%。</p><p><br/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-12-19 07:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><strong>周四美股成交额第1名 </strong><a href=\"https://laohu8.com/S/TSLA\">特斯拉 </a> <strong>收高3.45%，成交458.48亿美元。</strong></p><p style=\"text-align: justify;\">据媒体周四报道，马斯克上周在xAI位于旧金山的总部召开的全体员工大会上表示，如果公司能够成功度过未来两到三年的关键发展期，xAI将最终在人工智能竞赛中击败所有竞争对手。</p><p style=\"text-align: justify;\"><strong>第2名 </strong><a href=\"https://laohu8.com/S/NVDA\">英伟达 </a> <strong>收高1.87%，成交304.13亿美元。</strong></p><p style=\"text-align: justify;\">英伟达与美国政府将通过“创世纪使命”计划加大人工智能基础设施建设和研发投入。该公司周四表示，已与美国能源部签署谅解备忘录，概述合作重点以支持加速科学发现。</p><p style=\"text-align: justify;\"><strong>第3名 </strong><a href=\"https://laohu8.com/S/AVGO\">博通 </a> <strong>收高1.18%，成交178.66亿美元。</strong></p><p style=\"text-align: justify;\">摩根大通预计，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升，这意味着明年将新增超过1500亿美元的增量支出，而华尔街预测尚未计入资本支出带来的AI收入上行空间。</p><p style=\"text-align: justify;\">根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。这意味着明年将新增超过1500亿美元的增量支出，基本覆盖英伟达、AMD、博通和Marvell等核心AI芯片厂商的预期营收。</p><p style=\"text-align: justify;\"><strong>第4名 </strong><a href=\"https://laohu8.com/S/MU\">美光科技 </a> <strong>收高10.21%，成交162.48亿美元。</strong></p><p style=\"text-align: justify;\">该公司的财报显示其存储芯片需求强劲，且远超市场预期。</p><p style=\"text-align: justify;\">在面向分析师的财报电话会议上，这家主营计算机及人工智能服务器存储产品的企业表示，数据中心的需求是推动其产品销量增长的核心动力。</p><p style=\"text-align: justify;\">美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。</p><p style=\"text-align: justify;\">“我们的产品早已全面售罄。”美光科技业务总裁苏米特-萨达纳表示，“目前订单需求缺口巨大，这种供不应求的局面，在可预见的未来还将持续。”</p><p style=\"text-align: justify;\">美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。</p><p style=\"text-align: justify;\"><strong>第7名</strong><a href=\"https://laohu8.com/S/META\">Meta Platforms </a> <strong>收高2.30%，成交128.51亿美元。</strong></p><p style=\"text-align: justify;\">昨日有报道称谷歌联手Meta推进TorchTPU计划挑战英伟达AI芯片地位。该报道称，谷歌推进“TorchTPU”计划，提升TPU运行PyTorch性能，欲削弱英伟达AI计算市场霸主地位，并与Meta合作以降低企业迁移成本。</p><p style=\"text-align: justify;\"><strong>第8名 </strong><a href=\"https://laohu8.com/S/AMZN\">亚马逊 </a> <strong>收高2.48%，成交109.64亿美元。</strong></p><p style=\"text-align: justify;\">据报道，该公司正洽谈向OpenAI投资超100亿美元，并提供Trainium芯片及AWS算力资源，此举或使OpenAI估值突破5000亿美元，并扩大亚马逊在生成式AI领域的布局。</p><p style=\"text-align: justify;\"><strong>第9名 </strong><a href=\"https://laohu8.com/S/GOOGL\">谷歌-A </a> <strong>收高1.93%，成交97.47亿美元。</strong></p><p style=\"text-align: justify;\">周四有报道称，与Alphabet旗下谷歌公司相关的某数据中心开发商正计划发行12.8亿美元、五年期的垃圾债券（高收益债），为项目进行部分融资。</p><p style=\"text-align: justify;\">据知情人士透露，该交易由摩根士丹利领投，债券的定价收益率预计在7.25%左右。此次发行背景是投资者对AI“淘金热”的财务根基愈发感到不安，因为这一领域的扩张很大程度上是依赖借贷驱动的。</p><p style=\"text-align: justify;\"><strong>第10名 </strong><a href=\"https://laohu8.com/S/PLTR\">Palantir </a> <strong>收高4.74%，成交74.09亿美元。</strong></p><p style=\"text-align: justify;\"><strong>第15名</strong><a href=\"https://laohu8.com/S/LLY\">礼来 </a> <strong>收高1.45%，成交40.85亿美元。</strong></p><p style=\"text-align: justify;\">该公司宣布，其口服减肥药orforglipron在一项三期临床试验中显示出优于对照的体重维持效果，适用于此前已使用注射型减肥药（包括公司自身的Zepbound以及诺和诺德（NVO.US）的Wegovy）的肥胖或超重成年人。</p><p style=\"text-align: justify;\">礼来援引ATTAIN-MAINTAIN试验的顶线数据称，在为期52周的研究中，从Wegovy或Zepbound转换为orforglipron的患者，基本维持了此前通过注射药物获得的减重成果。数据显示，与对照相比，从Wegovy转换的患者体重平均差异为0.9公斤，从Zepbound转换的患者体重平均差异为5.0公斤。</p><p style=\"text-align: justify;\"><strong>第18名 </strong><a href=\"https://laohu8.com/S/TSM\">台积电 </a> <strong>收高2.79%，成交32亿美元。</strong></p><p style=\"text-align: justify;\">台积电2nm的量产工作会在今年底正式启动，目前两座工厂的2nm产能已经被预订一空，台积电需要额外新建工厂来满足客户需求，这项工程预计需要286亿美元的投资。据悉，苹果、高通、联发科、AMD等多家企业都是台积电2nm工艺的客户，台积电难以满足所有客户的需求，目前苹果拿下了超半数的初始产能，剩下的产能则由其它客户瓜分。按照计划，台积电将在2026年底前把月产量提升至10万片。</p><p style=\"text-align: justify;\">摩根士丹利上调台积电目标股价。</p><p style=\"text-align: justify;\"><strong>第20名 </strong><a href=\"https://laohu8.com/S/GEV\">GE Vernova </a> <strong>收高4.11%，成交28.51亿美元。</strong></p><p style=\"text-align: justify;\">受益于AI数据中心板块反弹以及杰富瑞分析师将其评级上调至“买入”。</p><p style=\"text-align: justify;\">杰富瑞分析师在周四发布的一份研报中写道：“我们上调其构配件至买入。我们对电力业务（燃气定价及服务可见性）和电气化前景更加乐观，但自12月9日分析师日以来股价却出现下跌。目标价上调至815美元，此前为736美元。燃气轮机定价持续带来正面惊喜，服务业务为2030年代中后期提供了清晰的能见度，最终将抵消燃气设备业务的疲软。”</p><p style=\"text-align: justify;\">该目标价略高于FactSet统计的市场一致预期目标价753美元，较GE Vernova周三收盘价溢价约23%。该股2025年迄今已累计上涨近100%。</p><p><br/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","relate_stocks":{"PLTR":"Palantir Technologies Inc.","MU":"美光科技","TSLA":"特斯拉"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191049562","content_text":"周四美股成交额第1名 特斯拉 收高3.45%，成交458.48亿美元。据媒体周四报道，马斯克上周在xAI位于旧金山的总部召开的全体员工大会上表示，如果公司能够成功度过未来两到三年的关键发展期，xAI将最终在人工智能竞赛中击败所有竞争对手。第2名 英伟达 收高1.87%，成交304.13亿美元。英伟达与美国政府将通过“创世纪使命”计划加大人工智能基础设施建设和研发投入。该公司周四表示，已与美国能源部签署谅解备忘录，概述合作重点以支持加速科学发现。第3名 博通 收高1.18%，成交178.66亿美元。摩根大通预计，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升，这意味着明年将新增超过1500亿美元的增量支出，而华尔街预测尚未计入资本支出带来的AI收入上行空间。根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。这意味着明年将新增超过1500亿美元的增量支出，基本覆盖英伟达、AMD、博通和Marvell等核心AI芯片厂商的预期营收。第4名 美光科技 收高10.21%，成交162.48亿美元。该公司的财报显示其存储芯片需求强劲，且远超市场预期。在面向分析师的财报电话会议上，这家主营计算机及人工智能服务器存储产品的企业表示，数据中心的需求是推动其产品销量增长的核心动力。美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。“我们的产品早已全面售罄。”美光科技业务总裁苏米特-萨达纳表示，“目前订单需求缺口巨大，这种供不应求的局面，在可预见的未来还将持续。”美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。第7名Meta Platforms 收高2.30%，成交128.51亿美元。昨日有报道称谷歌联手Meta推进TorchTPU计划挑战英伟达AI芯片地位。该报道称，谷歌推进“TorchTPU”计划，提升TPU运行PyTorch性能，欲削弱英伟达AI计算市场霸主地位，并与Meta合作以降低企业迁移成本。第8名 亚马逊 收高2.48%，成交109.64亿美元。据报道，该公司正洽谈向OpenAI投资超100亿美元，并提供Trainium芯片及AWS算力资源，此举或使OpenAI估值突破5000亿美元，并扩大亚马逊在生成式AI领域的布局。第9名 谷歌-A 收高1.93%，成交97.47亿美元。周四有报道称，与Alphabet旗下谷歌公司相关的某数据中心开发商正计划发行12.8亿美元、五年期的垃圾债券（高收益债），为项目进行部分融资。据知情人士透露，该交易由摩根士丹利领投，债券的定价收益率预计在7.25%左右。此次发行背景是投资者对AI“淘金热”的财务根基愈发感到不安，因为这一领域的扩张很大程度上是依赖借贷驱动的。第10名 Palantir 收高4.74%，成交74.09亿美元。第15名礼来 收高1.45%，成交40.85亿美元。该公司宣布，其口服减肥药orforglipron在一项三期临床试验中显示出优于对照的体重维持效果，适用于此前已使用注射型减肥药（包括公司自身的Zepbound以及诺和诺德（NVO.US）的Wegovy）的肥胖或超重成年人。礼来援引ATTAIN-MAINTAIN试验的顶线数据称，在为期52周的研究中，从Wegovy或Zepbound转换为orforglipron的患者，基本维持了此前通过注射药物获得的减重成果。数据显示，与对照相比，从Wegovy转换的患者体重平均差异为0.9公斤，从Zepbound转换的患者体重平均差异为5.0公斤。第18名 台积电 收高2.79%，成交32亿美元。台积电2nm的量产工作会在今年底正式启动，目前两座工厂的2nm产能已经被预订一空，台积电需要额外新建工厂来满足客户需求，这项工程预计需要286亿美元的投资。据悉，苹果、高通、联发科、AMD等多家企业都是台积电2nm工艺的客户，台积电难以满足所有客户的需求，目前苹果拿下了超半数的初始产能，剩下的产能则由其它客户瓜分。按照计划，台积电将在2026年底前把月产量提升至10万片。摩根士丹利上调台积电目标股价。第20名 GE Vernova 收高4.11%，成交28.51亿美元。受益于AI数据中心板块反弹以及杰富瑞分析师将其评级上调至“买入”。杰富瑞分析师在周四发布的一份研报中写道：“我们上调其构配件至买入。我们对电力业务（燃气定价及服务可见性）和电气化前景更加乐观，但自12月9日分析师日以来股价却出现下跌。目标价上调至815美元，此前为736美元。燃气轮机定价持续带来正面惊喜，服务业务为2030年代中后期提供了清晰的能见度，最终将抵消燃气设备业务的疲软。”该目标价略高于FactSet统计的市场一致预期目标价753美元，较GE Vernova周三收盘价溢价约23%。该股2025年迄今已累计上涨近100%。","news_type":1,"symbols_score_info":{"MU":2,"PLTR":2,"TSLA":2}},"isVote":1,"tweetType":1,"viewCount":1446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":511606243221704,"gmtCreate":1765930825793,"gmtModify":1765935754404,"author":{"id":"4113521397048440","authorId":"4113521397048440","name":"小朋戈","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4113521397048440","authorIdStr":"4113521397048440"},"themes":[],"title":"","htmlText":" ","listText":" ","text":"","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/511606243221704","repostId":"2592195596","repostType":2,"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":512315641295704,"gmtCreate":1766104094017,"gmtModify":1766109461993,"author":{"id":"4113521397048440","authorId":"4113521397048440","name":"小朋戈","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4113521397048440","idStr":"4113521397048440"},"themes":[],"title":"","htmlText":" ＇。 ＇; ","listText":" ＇。 ＇; ","text":"＇。 ＇;","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/512315641295704","repostId":"1191049562","repostType":2,"repost":{"id":"1191049562","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1766098908,"share":"https://www.laohunote.com/m/news/1191049562?lang=zh_CN&edition=full","pubTime":"2025-12-19 07:01","market":"us","language":"zh","title":"美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191049562","media":"老虎资讯综合","summary":"周四美股成交额第1名 $特斯拉 $ 收高3.45%，成交458.48亿美元。根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。第10名 $Palantir $ 收高4.74%，成交74.09亿美元。该股2025年迄今已累计上涨近100%。","content":"<html><head></head><body><p><strong>周四美股成交额第1名 </strong><a href=\"https://laohu8.com/S/TSLA\">特斯拉 </a> <strong>收高3.45%，成交458.48亿美元。</strong></p><p style=\"text-align: justify;\">据媒体周四报道，马斯克上周在xAI位于旧金山的总部召开的全体员工大会上表示，如果公司能够成功度过未来两到三年的关键发展期，xAI将最终在人工智能竞赛中击败所有竞争对手。</p><p style=\"text-align: justify;\"><strong>第2名 </strong><a href=\"https://laohu8.com/S/NVDA\">英伟达 </a> <strong>收高1.87%，成交304.13亿美元。</strong></p><p style=\"text-align: justify;\">英伟达与美国政府将通过“创世纪使命”计划加大人工智能基础设施建设和研发投入。该公司周四表示，已与美国能源部签署谅解备忘录，概述合作重点以支持加速科学发现。</p><p style=\"text-align: justify;\"><strong>第3名 </strong><a href=\"https://laohu8.com/S/AVGO\">博通 </a> <strong>收高1.18%，成交178.66亿美元。</strong></p><p style=\"text-align: justify;\">摩根大通预计，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升，这意味着明年将新增超过1500亿美元的增量支出，而华尔街预测尚未计入资本支出带来的AI收入上行空间。</p><p style=\"text-align: justify;\">根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。这意味着明年将新增超过1500亿美元的增量支出，基本覆盖英伟达、AMD、博通和Marvell等核心AI芯片厂商的预期营收。</p><p style=\"text-align: justify;\"><strong>第4名 </strong><a href=\"https://laohu8.com/S/MU\">美光科技 </a> <strong>收高10.21%，成交162.48亿美元。</strong></p><p style=\"text-align: justify;\">该公司的财报显示其存储芯片需求强劲，且远超市场预期。</p><p style=\"text-align: justify;\">在面向分析师的财报电话会议上，这家主营计算机及人工智能服务器存储产品的企业表示，数据中心的需求是推动其产品销量增长的核心动力。</p><p style=\"text-align: justify;\">美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。</p><p style=\"text-align: justify;\">“我们的产品早已全面售罄。”美光科技业务总裁苏米特-萨达纳表示，“目前订单需求缺口巨大，这种供不应求的局面，在可预见的未来还将持续。”</p><p style=\"text-align: justify;\">美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。</p><p style=\"text-align: justify;\"><strong>第7名</strong><a href=\"https://laohu8.com/S/META\">Meta Platforms </a> <strong>收高2.30%，成交128.51亿美元。</strong></p><p style=\"text-align: justify;\">昨日有报道称谷歌联手Meta推进TorchTPU计划挑战英伟达AI芯片地位。该报道称，谷歌推进“TorchTPU”计划，提升TPU运行PyTorch性能，欲削弱英伟达AI计算市场霸主地位，并与Meta合作以降低企业迁移成本。</p><p style=\"text-align: justify;\"><strong>第8名 </strong><a href=\"https://laohu8.com/S/AMZN\">亚马逊 </a> <strong>收高2.48%，成交109.64亿美元。</strong></p><p style=\"text-align: justify;\">据报道，该公司正洽谈向OpenAI投资超100亿美元，并提供Trainium芯片及AWS算力资源，此举或使OpenAI估值突破5000亿美元，并扩大亚马逊在生成式AI领域的布局。</p><p style=\"text-align: justify;\"><strong>第9名 </strong><a href=\"https://laohu8.com/S/GOOGL\">谷歌-A </a> <strong>收高1.93%，成交97.47亿美元。</strong></p><p style=\"text-align: justify;\">周四有报道称，与Alphabet旗下谷歌公司相关的某数据中心开发商正计划发行12.8亿美元、五年期的垃圾债券（高收益债），为项目进行部分融资。</p><p style=\"text-align: justify;\">据知情人士透露，该交易由摩根士丹利领投，债券的定价收益率预计在7.25%左右。此次发行背景是投资者对AI“淘金热”的财务根基愈发感到不安，因为这一领域的扩张很大程度上是依赖借贷驱动的。</p><p style=\"text-align: justify;\"><strong>第10名 </strong><a href=\"https://laohu8.com/S/PLTR\">Palantir </a> <strong>收高4.74%，成交74.09亿美元。</strong></p><p style=\"text-align: justify;\"><strong>第15名</strong><a href=\"https://laohu8.com/S/LLY\">礼来 </a> <strong>收高1.45%，成交40.85亿美元。</strong></p><p style=\"text-align: justify;\">该公司宣布，其口服减肥药orforglipron在一项三期临床试验中显示出优于对照的体重维持效果，适用于此前已使用注射型减肥药（包括公司自身的Zepbound以及诺和诺德（NVO.US）的Wegovy）的肥胖或超重成年人。</p><p style=\"text-align: justify;\">礼来援引ATTAIN-MAINTAIN试验的顶线数据称，在为期52周的研究中，从Wegovy或Zepbound转换为orforglipron的患者，基本维持了此前通过注射药物获得的减重成果。数据显示，与对照相比，从Wegovy转换的患者体重平均差异为0.9公斤，从Zepbound转换的患者体重平均差异为5.0公斤。</p><p style=\"text-align: justify;\"><strong>第18名 </strong><a href=\"https://laohu8.com/S/TSM\">台积电 </a> <strong>收高2.79%，成交32亿美元。</strong></p><p style=\"text-align: justify;\">台积电2nm的量产工作会在今年底正式启动，目前两座工厂的2nm产能已经被预订一空，台积电需要额外新建工厂来满足客户需求，这项工程预计需要286亿美元的投资。据悉，苹果、高通、联发科、AMD等多家企业都是台积电2nm工艺的客户，台积电难以满足所有客户的需求，目前苹果拿下了超半数的初始产能，剩下的产能则由其它客户瓜分。按照计划，台积电将在2026年底前把月产量提升至10万片。</p><p style=\"text-align: justify;\">摩根士丹利上调台积电目标股价。</p><p style=\"text-align: justify;\"><strong>第20名 </strong><a href=\"https://laohu8.com/S/GEV\">GE Vernova </a> <strong>收高4.11%，成交28.51亿美元。</strong></p><p style=\"text-align: justify;\">受益于AI数据中心板块反弹以及杰富瑞分析师将其评级上调至“买入”。</p><p style=\"text-align: justify;\">杰富瑞分析师在周四发布的一份研报中写道：“我们上调其构配件至买入。我们对电力业务（燃气定价及服务可见性）和电气化前景更加乐观，但自12月9日分析师日以来股价却出现下跌。目标价上调至815美元，此前为736美元。燃气轮机定价持续带来正面惊喜，服务业务为2030年代中后期提供了清晰的能见度，最终将抵消燃气设备业务的疲软。”</p><p style=\"text-align: justify;\">该目标价略高于FactSet统计的市场一致预期目标价753美元，较GE Vernova周三收盘价溢价约23%。该股2025年迄今已累计上涨近100%。</p><p><br/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股成交额TOP 20 | 美光科技绩后涨超10%， Palantir涨超4%，特斯拉涨超3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-12-19 07:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><strong>周四美股成交额第1名 </strong><a href=\"https://laohu8.com/S/TSLA\">特斯拉 </a> <strong>收高3.45%，成交458.48亿美元。</strong></p><p style=\"text-align: justify;\">据媒体周四报道，马斯克上周在xAI位于旧金山的总部召开的全体员工大会上表示，如果公司能够成功度过未来两到三年的关键发展期，xAI将最终在人工智能竞赛中击败所有竞争对手。</p><p style=\"text-align: justify;\"><strong>第2名 </strong><a href=\"https://laohu8.com/S/NVDA\">英伟达 </a> <strong>收高1.87%，成交304.13亿美元。</strong></p><p style=\"text-align: justify;\">英伟达与美国政府将通过“创世纪使命”计划加大人工智能基础设施建设和研发投入。该公司周四表示，已与美国能源部签署谅解备忘录，概述合作重点以支持加速科学发现。</p><p style=\"text-align: justify;\"><strong>第3名 </strong><a href=\"https://laohu8.com/S/AVGO\">博通 </a> <strong>收高1.18%，成交178.66亿美元。</strong></p><p style=\"text-align: justify;\">摩根大通预计，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升，这意味着明年将新增超过1500亿美元的增量支出，而华尔街预测尚未计入资本支出带来的AI收入上行空间。</p><p style=\"text-align: justify;\">根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。这意味着明年将新增超过1500亿美元的增量支出，基本覆盖英伟达、AMD、博通和Marvell等核心AI芯片厂商的预期营收。</p><p style=\"text-align: justify;\"><strong>第4名 </strong><a href=\"https://laohu8.com/S/MU\">美光科技 </a> <strong>收高10.21%，成交162.48亿美元。</strong></p><p style=\"text-align: justify;\">该公司的财报显示其存储芯片需求强劲，且远超市场预期。</p><p style=\"text-align: justify;\">在面向分析师的财报电话会议上，这家主营计算机及人工智能服务器存储产品的企业表示，数据中心的需求是推动其产品销量增长的核心动力。</p><p style=\"text-align: justify;\">美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。</p><p style=\"text-align: justify;\">“我们的产品早已全面售罄。”美光科技业务总裁苏米特-萨达纳表示，“目前订单需求缺口巨大，这种供不应求的局面，在可预见的未来还将持续。”</p><p style=\"text-align: justify;\">美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。</p><p style=\"text-align: justify;\"><strong>第7名</strong><a href=\"https://laohu8.com/S/META\">Meta Platforms </a> <strong>收高2.30%，成交128.51亿美元。</strong></p><p style=\"text-align: justify;\">昨日有报道称谷歌联手Meta推进TorchTPU计划挑战英伟达AI芯片地位。该报道称，谷歌推进“TorchTPU”计划，提升TPU运行PyTorch性能，欲削弱英伟达AI计算市场霸主地位，并与Meta合作以降低企业迁移成本。</p><p style=\"text-align: justify;\"><strong>第8名 </strong><a href=\"https://laohu8.com/S/AMZN\">亚马逊 </a> <strong>收高2.48%，成交109.64亿美元。</strong></p><p style=\"text-align: justify;\">据报道，该公司正洽谈向OpenAI投资超100亿美元，并提供Trainium芯片及AWS算力资源，此举或使OpenAI估值突破5000亿美元，并扩大亚马逊在生成式AI领域的布局。</p><p style=\"text-align: justify;\"><strong>第9名 </strong><a href=\"https://laohu8.com/S/GOOGL\">谷歌-A </a> <strong>收高1.93%，成交97.47亿美元。</strong></p><p style=\"text-align: justify;\">周四有报道称，与Alphabet旗下谷歌公司相关的某数据中心开发商正计划发行12.8亿美元、五年期的垃圾债券（高收益债），为项目进行部分融资。</p><p style=\"text-align: justify;\">据知情人士透露，该交易由摩根士丹利领投，债券的定价收益率预计在7.25%左右。此次发行背景是投资者对AI“淘金热”的财务根基愈发感到不安，因为这一领域的扩张很大程度上是依赖借贷驱动的。</p><p style=\"text-align: justify;\"><strong>第10名 </strong><a href=\"https://laohu8.com/S/PLTR\">Palantir </a> <strong>收高4.74%，成交74.09亿美元。</strong></p><p style=\"text-align: justify;\"><strong>第15名</strong><a href=\"https://laohu8.com/S/LLY\">礼来 </a> <strong>收高1.45%，成交40.85亿美元。</strong></p><p style=\"text-align: justify;\">该公司宣布，其口服减肥药orforglipron在一项三期临床试验中显示出优于对照的体重维持效果，适用于此前已使用注射型减肥药（包括公司自身的Zepbound以及诺和诺德（NVO.US）的Wegovy）的肥胖或超重成年人。</p><p style=\"text-align: justify;\">礼来援引ATTAIN-MAINTAIN试验的顶线数据称，在为期52周的研究中，从Wegovy或Zepbound转换为orforglipron的患者，基本维持了此前通过注射药物获得的减重成果。数据显示，与对照相比，从Wegovy转换的患者体重平均差异为0.9公斤，从Zepbound转换的患者体重平均差异为5.0公斤。</p><p style=\"text-align: justify;\"><strong>第18名 </strong><a href=\"https://laohu8.com/S/TSM\">台积电 </a> <strong>收高2.79%，成交32亿美元。</strong></p><p style=\"text-align: justify;\">台积电2nm的量产工作会在今年底正式启动，目前两座工厂的2nm产能已经被预订一空，台积电需要额外新建工厂来满足客户需求，这项工程预计需要286亿美元的投资。据悉，苹果、高通、联发科、AMD等多家企业都是台积电2nm工艺的客户，台积电难以满足所有客户的需求，目前苹果拿下了超半数的初始产能，剩下的产能则由其它客户瓜分。按照计划，台积电将在2026年底前把月产量提升至10万片。</p><p style=\"text-align: justify;\">摩根士丹利上调台积电目标股价。</p><p style=\"text-align: justify;\"><strong>第20名 </strong><a href=\"https://laohu8.com/S/GEV\">GE Vernova </a> <strong>收高4.11%，成交28.51亿美元。</strong></p><p style=\"text-align: justify;\">受益于AI数据中心板块反弹以及杰富瑞分析师将其评级上调至“买入”。</p><p style=\"text-align: justify;\">杰富瑞分析师在周四发布的一份研报中写道：“我们上调其构配件至买入。我们对电力业务（燃气定价及服务可见性）和电气化前景更加乐观，但自12月9日分析师日以来股价却出现下跌。目标价上调至815美元，此前为736美元。燃气轮机定价持续带来正面惊喜，服务业务为2030年代中后期提供了清晰的能见度，最终将抵消燃气设备业务的疲软。”</p><p style=\"text-align: justify;\">该目标价略高于FactSet统计的市场一致预期目标价753美元，较GE Vernova周三收盘价溢价约23%。该股2025年迄今已累计上涨近100%。</p><p><br/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","relate_stocks":{"PLTR":"Palantir Technologies Inc.","MU":"美光科技","TSLA":"特斯拉"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191049562","content_text":"周四美股成交额第1名 特斯拉 收高3.45%，成交458.48亿美元。据媒体周四报道，马斯克上周在xAI位于旧金山的总部召开的全体员工大会上表示，如果公司能够成功度过未来两到三年的关键发展期，xAI将最终在人工智能竞赛中击败所有竞争对手。第2名 英伟达 收高1.87%，成交304.13亿美元。英伟达与美国政府将通过“创世纪使命”计划加大人工智能基础设施建设和研发投入。该公司周四表示，已与美国能源部签署谅解备忘录，概述合作重点以支持加速科学发现。第3名 博通 收高1.18%，成交178.66亿美元。摩根大通预计，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升，这意味着明年将新增超过1500亿美元的增量支出，而华尔街预测尚未计入资本支出带来的AI收入上行空间。根据报告，2026年数据中心资本开支增速预计将超过50%，较此前30%的预期大幅提升。这意味着明年将新增超过1500亿美元的增量支出，基本覆盖英伟达、AMD、博通和Marvell等核心AI芯片厂商的预期营收。第4名 美光科技 收高10.21%，成交162.48亿美元。该公司的财报显示其存储芯片需求强劲，且远超市场预期。在面向分析师的财报电话会议上，这家主营计算机及人工智能服务器存储产品的企业表示，数据中心的需求是推动其产品销量增长的核心动力。美光科技预计，到2028年，高带宽存储芯片的潜在总市场规模将达到1000亿美元，年复合增长率高达40%。公司管理层同时将资本支出指引从180亿美元上调至200亿美元。“我们的产品早已全面售罄。”美光科技业务总裁苏米特-萨达纳表示，“目前订单需求缺口巨大，这种供不应求的局面，在可预见的未来还将持续。”美光科技不仅超出华尔街对其第一财季的业绩预期，还给出了超亮眼的业绩指引。第7名Meta Platforms 收高2.30%，成交128.51亿美元。昨日有报道称谷歌联手Meta推进TorchTPU计划挑战英伟达AI芯片地位。该报道称，谷歌推进“TorchTPU”计划，提升TPU运行PyTorch性能，欲削弱英伟达AI计算市场霸主地位，并与Meta合作以降低企业迁移成本。第8名 亚马逊 收高2.48%，成交109.64亿美元。据报道，该公司正洽谈向OpenAI投资超100亿美元，并提供Trainium芯片及AWS算力资源，此举或使OpenAI估值突破5000亿美元，并扩大亚马逊在生成式AI领域的布局。第9名 谷歌-A 收高1.93%，成交97.47亿美元。周四有报道称，与Alphabet旗下谷歌公司相关的某数据中心开发商正计划发行12.8亿美元、五年期的垃圾债券（高收益债），为项目进行部分融资。据知情人士透露，该交易由摩根士丹利领投，债券的定价收益率预计在7.25%左右。此次发行背景是投资者对AI“淘金热”的财务根基愈发感到不安，因为这一领域的扩张很大程度上是依赖借贷驱动的。第10名 Palantir 收高4.74%，成交74.09亿美元。第15名礼来 收高1.45%，成交40.85亿美元。该公司宣布，其口服减肥药orforglipron在一项三期临床试验中显示出优于对照的体重维持效果，适用于此前已使用注射型减肥药（包括公司自身的Zepbound以及诺和诺德（NVO.US）的Wegovy）的肥胖或超重成年人。礼来援引ATTAIN-MAINTAIN试验的顶线数据称，在为期52周的研究中，从Wegovy或Zepbound转换为orforglipron的患者，基本维持了此前通过注射药物获得的减重成果。数据显示，与对照相比，从Wegovy转换的患者体重平均差异为0.9公斤，从Zepbound转换的患者体重平均差异为5.0公斤。第18名 台积电 收高2.79%，成交32亿美元。台积电2nm的量产工作会在今年底正式启动，目前两座工厂的2nm产能已经被预订一空，台积电需要额外新建工厂来满足客户需求，这项工程预计需要286亿美元的投资。据悉，苹果、高通、联发科、AMD等多家企业都是台积电2nm工艺的客户，台积电难以满足所有客户的需求，目前苹果拿下了超半数的初始产能，剩下的产能则由其它客户瓜分。按照计划，台积电将在2026年底前把月产量提升至10万片。摩根士丹利上调台积电目标股价。第20名 GE Vernova 收高4.11%，成交28.51亿美元。受益于AI数据中心板块反弹以及杰富瑞分析师将其评级上调至“买入”。杰富瑞分析师在周四发布的一份研报中写道：“我们上调其构配件至买入。我们对电力业务（燃气定价及服务可见性）和电气化前景更加乐观，但自12月9日分析师日以来股价却出现下跌。目标价上调至815美元，此前为736美元。燃气轮机定价持续带来正面惊喜，服务业务为2030年代中后期提供了清晰的能见度，最终将抵消燃气设备业务的疲软。”该目标价略高于FactSet统计的市场一致预期目标价753美元，较GE Vernova周三收盘价溢价约23%。该股2025年迄今已累计上涨近100%。","news_type":1,"symbols_score_info":{"MU":2,"PLTR":2,"TSLA":2}},"isVote":1,"tweetType":1,"viewCount":1446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":511606243221704,"gmtCreate":1765930825793,"gmtModify":1765935754404,"author":{"id":"4113521397048440","authorId":"4113521397048440","name":"小朋戈","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4113521397048440","idStr":"4113521397048440"},"themes":[],"title":"","htmlText":" ","listText":" ","text":"","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/511606243221704","repostId":"2592195596","repostType":2,"repost":{"id":"2592195596","kind":"news","pubTimestamp":1765927451,"share":"https://www.laohunote.com/m/news/2592195596?lang=zh_CN&edition=full","pubTime":"2025-12-17 07:24","market":"us","language":"zh","title":"苹果iPhone Air 2将有两大改变：双摄设计＋价格下调","url":"https://stock-news.laohu8.com/highlight/detail?id=2592195596","media":"手机中国","summary":"据外媒报道，苹果正着手从产品配置与定价策略两方面优化iPhone Air 2，以提升该系列的竞争力。目前初代iPhone Air自上市以来，虽然凭借超薄设计和轻量化机身吸引了部分关注，但整体销量表现未达预期，已导致供应链大幅削减生产计划。为弥补产品短板，苹果正在考虑为iPhone Air 2新增第二颗后置摄像头。与此同时，苹果也在评估下调iPhone Air 2的起售价。","content":"<html><body><article><p>【CNMO科技消息】据外媒报道，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>正着手从产品配置与定价策略两方面优化iPhone Air 2，以提升该系列的竞争力。目前初代iPhone Air自上市以来，虽然凭借超薄设计和轻量化机身吸引了部分关注，但整体销量表现未达预期，已导致供应链大幅削减生产计划。</p><img src=\"https://inews.gtimg.com/om_bt/O9pGygE9gM7FbC9IXXO8HizzyZnc5BihZ6ZHIBRVrzqAoAA/0\"/><p>为弥补产品短板，苹果正在考虑为iPhone Air 2新增第二颗后置摄像头。现款iPhone Air仅配备一颗4800万像素融合式主摄，虽通过传感器裁切实现光学品质的2倍变焦效果，但缺乏超广角镜头，在多场景拍摄能力上存在明显局限。知情人士透露，新一代机型极有可能加入超广角镜头，从而构建更完整的影像系统。</p><p>与此同时，苹果也在评估下调iPhone Air 2的起售价。当前iPhone Air在中国市场的起售价为7999元，但其配置相较同价位机型存在一定差距——除单摄外，还采用单扬声器设计、电池续航较短，并缺少部分高端功能。高定价与功能精简之间的落差，被认为是影响消费者购买意愿的关键因素。</p><img src=\"https://inews.gtimg.com/om_bt/OKeGn4jj-g3POch5TEYCltjxzUTEahk-7eyCTw6HHshVMAA/0\"/><p>有分析指出，iPhone Air定位介于标准版与Pro系列之间，主打极致轻薄与时尚外观，但若缺乏核心体验支撑，难以在iPhone 17及iPhone 17 Pro等主力机型的强势销售下突围。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>苹果iPhone Air 2将有两大改变：双摄设计＋价格下调</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n苹果iPhone Air 2将有两大改变：双摄设计＋价格下调\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-17 07:24 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217072644a4541a22&s=b><strong>手机中国</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【CNMO科技消息】据外媒报道，苹果正着手从产品配置与定价策略两方面优化iPhone Air 2，以提升该系列的竞争力。目前初代iPhone Air自上市以来，虽然凭借超薄设计和轻量化机身吸引了部分关注，但整体销量表现未达预期，已导致供应链大幅削减生产计划。为弥补产品短板，苹果正在考虑为iPhone Air 2新增第二颗后置摄像头。现款iPhone Air仅配备一颗4800万像素融合式主摄，虽通过...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217072644a4541a22&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IE00B4JS1V06.HKD":"JANUS HENDERSON BALANCED \"A2\" (HKD) ACC","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","BK4515":"5G概念","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU2360106780.USD":"BGF WORLD TECHNOLOGY \"A4\" (USD) INC","LU0082616367.USD":"摩根大通美国科技A（dist）","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","LU1803068979.SGD":"FTIF - Franklin Technology A (acc) SGD-H1","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU1206713676.USD":"Aviva Investors - Multi-Strategy Target Return Ah USD","BK4512":"苹果概念","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU2083900584.USD":"HSBC GIF US INCOME FOCUSED \"AM2\" (USD) INC","LU1206712785.SGD":"Aviva Investors - Multi-Strategy Target Return Ah SGD","LU0472753341.HKD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (HKD) ACC","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU2242649171.HKD":"FIDELITY FUNDS GLOBAL THEMATIC OPPORTUNITIES \"A\" (HKD) ACC","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU1934455863.HKD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","BK4170":"电脑硬件、储存设备及电脑周边","LU0949170426.SGD":"Blackrock Global Multi-Asset Income A6 SGD-H","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0784384876.USD":"Blackrock Global Multi-Asset Income A6 USD","IE00BN29S564.USD":"JANUS HENDERSON BALANCED \"A3\" (USD) INC","LU2125154935.USD":"ALLSPRING (LUX) WF GLOBAL EQUITY ENHANCED INCOME \"I\" (USD) INC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","IE00BFSS8Q28.SGD":"Janus Henderson Balanced A Inc SGD-H","LU1366333091.USD":"FIDELITY GLOBAL FOCUS \"A\" (USD) ACC","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","AAPL":"苹果","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0048584097.USD":"FIDELITY FUNDS GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) INC","IE0009G5SDU7.USD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (USD) INC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE0001KFT4U8.USD":"FTGF CLEARBRIDGE GLOBAL GROWTH LEADERS \"A\" (USD) INC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","IE000ITXATA3.USD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (USD) ACC","IE000YTNTUN2.SGD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (SGDHDG)INC","BK4505":"高瓴资本持仓","BK4571":"数字音乐概念","BK4576":"AR","LU1145028129.USD":"ALLIANZ INCOME AND GROWTH \"AQ\" (USD) INC","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","BK4575":"芯片概念","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU0157215616.USD":"FIDELITY GLOBAL FOCUS \"A\" INC","BK4501":"段永平概念","LU0353189763.USD":"ALLSPRING US ALL CAP GROWTH FUND \"I\" (USD) ACC","BK4579":"人工智能","IE00BJTD4N35.SGD":"Neuberger Berman US Long Short Equity A1 Acc SGD-H","BK4574":"无人驾驶","BK4573":"虚拟现实","BK4507":"流媒体概念","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","LU2247934214.USD":"FIDELITY FUNDS SUSTAINABLE FUTURE CONNECTIVITY \"A\" (USD) ACC","BK4581":"高盛持仓","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU0354030511.USD":"ALLSPRING U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU0787776722.HKD":"AB SELECT US EQUITY PORTFOLIO \"A\" (HKD) ACC","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU0251132253.USD":"FIDELITY FUNDS GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) ACC","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU0476273544.USD":"CT (LUX) I GLOBAL TECHNOLOGY \"BU\" (USD) ACC","BK4534":"瑞士信贷持仓","LU1732800096.USD":"摩根大通环球收益基金A (irc)","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU1917777945.USD":"安联专题基金Cl AT Acc","BK4532":"文艺复兴科技持仓","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) INC (M)","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0149725797.USD":"汇丰美国股市经济规模基金","LU2242650005.HKD":"FIDELITY FUNDS GLOBAL MULTI ASSET DYNAMIC \"A\" (HKD) ACC","LU0964807845.USD":"ALLIANZ INCOME & GROWTH \"A\" (USD) INC","LU0784385840.USD":"Blackrock Global Multi-Asset Income A2 USD","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU2063271972.USD":"富兰克林创新领域基金","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU2237443895.HKD":"abrdn SICAV I - GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU0784383803.USD":"BGF GLOBAL MULTI-ASSET INCOME FUND \"A\" (USD) INC A","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","BK4527":"明星科技股","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU0308772762.SGD":"Blackrock Global Allocation A2 SGD-H","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU2054465674.USD":"UBS (LUX) KEY SELEC SICAV DIGITAL TRANSFORMATION T \"P\" (USD) ACC","LU0056508442.USD":"贝莱德世界科技基金A2","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU2403377893.USD":"ALLIANZ SELECT INCOME AND GROWTH \"AM\" (USD) INC","LU0215105999.USD":"SCHRODER ISF GLOBAL EQUITY \"A\" ACC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0072462426.USD":"贝莱德全球配置 A2","LU2250418816.HKD":"BGF WORLD TECHNOLOGY \"A\" (HKD) ACC","IE0005OL40V9.USD":"JANUS HENDERSON BALANCED \"A6M\" (USD) INC","IE00BJTD4V19.USD":"NEUBERGER BERMAN US LONG SHORT EQUITY \"A1\" (USD) ACC","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU1301847155.USD":"BGF GLOBAL MULTI-ASSET INCOME FUND \"A4G\" (USD) INC","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU1046421795.USD":"富达环球科技A-ACC","LU1235294995.USD":"FIDELITY GLOBAL TECHNOLOGY \"A\" (USDHDG) ACC","LU2286300806.USD":"Allianz Cyber Security AT Acc USD","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","BK4550":"红杉资本持仓","SG9999002232.USD":"Allianz Global High Payout USD","BK4559":"巴菲特持仓","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU2087625088.SGD":"ALLSPRING US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","BK4553":"喜马拉雅资本持仓","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY \"A\" (USD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","BK4554":"元宇宙及AR概念","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU1935043023.USD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (USD) INC A","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","SG9999014906.USD":"大华全球优质成长基金Acc USD","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU0345768740.USD":"NINETY ONE GSF GLOBAL STRATEGIC MANAGED \"A\" (USD) INC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","IE00B5949003.HKD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU0070217475.USD":"JPM GLOBAL SELECT EQUITY \"A\" ACC","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU0726765562.USD":"JPM GLOBAL INCOME \"A\" (USD HEDGED) INC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU2347655073.USD":"JPM GLOBAL INCOME \"A\" (USDHDG) INC A","SG9999014914.USD":"UNITED GLOBAL QUALITY GROWTH (USDHDG) INC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","BK4588":"碎股","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","IE00B3SWFQ91.USD":"PIMCO BALANCED INCOME AND GROWTH \"E\" (USD) INC","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","LU0210533765.USD":"JPM GLOBAL GROWTH \"A\" (USD) ACC","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","BK4598":"佩洛西持仓","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","SG9999001424.SGD":"United E-Commerce Fund SGD","LU0097036916.USD":"贝莱德美国增长A2 USD","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU1642822529.SGD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"A\" (SGD) ACC","LU2191332357.HKD":"SCHRODER ISF SUSTAINABLE MULTI-ASSET INCOME \"A\" (HKDHDG) INC","LU0444973449.USD":"CT (LUX) I GLOBAL TECHNOLOGY \"DU\" (USD) ACC","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","LU2420271590.USD":"ALLIANZ SELECT INCOME AND GROWTH \"AT\" (USD) ACC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU2552382058.USD":"WELLINGTON US BRAND POWER \"A\" (USD) ACC","LU0823421333.USD":"BNP PARIBAS DISRUPTIVE TECHNOLOGY \"C\" (USD) ACC","LU2552382132.HKD":"WELLINGTON US BRAND POWER \"A\" (HKD) ACC","LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","LU0823421416.USD":"BNP PARIBAS DISRUPTIVE TECHNOLOGY \"C\" (USD) INC","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"AG\" (USD) ACC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","LU1935042215.USD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (USD) INC A","IE0003U64NQ7.SGD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (SGDHDG) ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU2458330169.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A\" (SGD) ACC","LU2458330243.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A-H1\" (SGDHDG) ACC","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","IE000KEQY171.SGD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (SGDHDG) INC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0109392836.USD":"富兰克林科技股A","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU1582986359.USD":"M&G (LUX) INCOME ALLOCATION \"A-H\" (USDHDG) ACC","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU0444971666.USD":"天利全球科技基金","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","IE00B4YYXB79.USD":"PIMCO BALANCED INCOME AND GROWTH \"E\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU2168564495.EUR":"AZ ALLOCATION - TREND \"AI\" (EUR) ACC","LU0210528500.USD":"JPM AMERICA EQUITY \"A\" ACC","LU0069063385.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (USD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2168564222.USD":"AZ ALLOCATION - TREND \"AAZ\" (USDHDG) ACC","LU1629891620.HKD":"ALLIANZ INCOME AND GROWTH \"AMG2\" (H2-HKD) INC","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","LU2487616109.SGD":"JPM AMERICA EQUITY \"A\" (SGD) ACC","LU1935042488.USD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (USD) INC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (SGDHDG) INC","LU2168563687.JPY":"AZ ALLOCATION - TREND \"AAZ\" (JPYHDG) ACC","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","LU2168564149.EUR":"AZ ALLOCATION - TREND \"BAZ\" (EUR) ACC","LU2896262040.SGD":"JPM US GROWTH FUND \"A\" (SGD) ACC","LU0203202063.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A2X\" (USD) ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE000W1ABFV2.USD":"PIMCO BALANCED INCOME AND GROWTH \"R\" (USD) INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0210536198.USD":"JPM US GROWTH \"A\" ACC","LU2023250330.USD":"ALLIANZ INCOME AND GROWTH \"AMG\" (USD) INC","LU0203201768.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"AX\" (USD) INC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0861579265.USD":"联博低波幅策略股票基金A","LU0057025933.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (USD) ACC","LU2452424414.USD":"BGF ESG MULTI-ASSET \"A10\" (USDHDG) INC","LU0882574139.USD":"富达环球消费行业基金A ACC","SG9999015978.USD":"利安颠覆性创新基金A","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","LU0784385170.HKD":"BGF GLOBAL MULTI ASSET INCOME \"A6\" (HKDHGD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","LU1935043536.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (SGDHDG) INC A","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU2213496289.HKD":"ALLIANZ INCOME AND GROWTH \"AT\" (HKD) ACC","LU1037948897.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (HKD) INC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0345768153.USD":"NINETY ONE GSF GLOBAL STRATEGIC MANAGED \"A\" (USD) ACC","BK4566":"资本集团","LU1815336760.USD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"AUP\" (USD) INC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","SG9999000418.SGD":"Aberdeen Standard Global Technology SGD","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","LU2860962120.EUR":"CPR INVEST - ARTIFICIAL INTELLIGENCE \"A2\" (EUR) ACC A","LU1037948541.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (HKD) ACC","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","LU1582987597.SGD":"M&G (LUX) INCOME ALLOCATION \"A-H\" (SGDHDG) INC","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU1582987324.SGD":"M&G (LUX) INCOME ALLOCATION \"A-H\" (SGDHDG) ACC","LU2092937148.SGD":"Blackrock ESG Multi-Asset A8 SGD-H","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","LU2092627202.USD":"Blackrock ESG Multi-Asset A8 USD-H","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","SG9999014559.SGD":"United Income Focus Trust Dis SGD","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","LU2077746001.SGD":"Blackrock ESG Multi-Asset A2 SGD-H","SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","LU1232071149.USD":"AZ FUND 1 GLOBAL GROWTH SELECTOR \"AAZ\" (USDHDG) ACC","LU0724617625.USD":"BGF GLOBAL ALLOCATION \"A4\" (USD) INC","LU2237443465.HKD":"abrdn SICAV I - GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU0788109477.HKD":"BGF GLOBAL ALLOCATION \"A2\" (HKDHGD) ACC","MACW.SI":"APPLE 3xLongSG261006","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","SG9999015358.SGD":"United Income Focus Trust Dis SGD-H","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU2381873111.SGD":"BGF SYSTEMATIC GLOBAL EQUITY HIGH INCOME \"A6\" (SGDHDG) INC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","LU0080751232.USD":"富达环球多元动力基金A","LU2097344431.USD":"SCHRODER ISF SUSTAINABLE MULTI-ASSET INCOME \"A\" (USDHDG) INC","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","LU0079474960.USD":"联博美国增长基金A","LU0957808578.USD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"ZU\" (USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","LU2097344357.USD":"SCHRODER ISF SUSTAINABLE MULTI-ASSET INCOME \"A\" (USDHDG) ACC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU2746668974.SGD":"MANULIFE DYNAMIC LEADERS \"AA\" (SGDHDG) ACC","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU0683600562.USD":"AB SELECT US EQUITY \"A\" (USD) ACC","LU0494093205.USD":"贝莱德ESG灵活多元资产A2 USD-H","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","LU2746668461.USD":"MANULIFE DYNAMIC LEADERS \"AA\" (USD) ACC","BK4592":"伊斯兰概念","LU1582986433.USD":"M&G (LUX) INCOME ALLOCATION \"A-H\" (USDHDG) INC","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217072644a4541a22&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2592195596","content_text":"【CNMO科技消息】据外媒报道，苹果正着手从产品配置与定价策略两方面优化iPhone Air 2，以提升该系列的竞争力。目前初代iPhone Air自上市以来，虽然凭借超薄设计和轻量化机身吸引了部分关注，但整体销量表现未达预期，已导致供应链大幅削减生产计划。为弥补产品短板，苹果正在考虑为iPhone Air 2新增第二颗后置摄像头。现款iPhone Air仅配备一颗4800万像素融合式主摄，虽通过传感器裁切实现光学品质的2倍变焦效果，但缺乏超广角镜头，在多场景拍摄能力上存在明显局限。知情人士透露，新一代机型极有可能加入超广角镜头，从而构建更完整的影像系统。与此同时，苹果也在评估下调iPhone Air 2的起售价。当前iPhone Air在中国市场的起售价为7999元，但其配置相较同价位机型存在一定差距——除单摄外，还采用单扬声器设计、电池续航较短，并缺少部分高端功能。高定价与功能精简之间的落差，被认为是影响消费者购买意愿的关键因素。有分析指出，iPhone Air定位介于标准版与Pro系列之间，主打极致轻薄与时尚外观，但若缺乏核心体验支撑，难以在iPhone 17及iPhone 17 Pro等主力机型的强势销售下突围。","news_type":1,"symbols_score_info":{"AAPL":1.95,"MACW.SI":0.6}},"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":603969722180896,"gmtCreate":1788490584676,"gmtModify":1788491314353,"author":{"id":"4113521397048440","authorId":"4113521397048440","name":"小朋戈","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4113521397048440","idStr":"4113521397048440"},"themes":[],"title":"","htmlText":"班","listText":"班","text":"班","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603969722180896","repostId":"2664383605","repostType":2,"repost":{"id":"2664383605","kind":"news","pubTimestamp":1788487320,"share":"https://www.laohunote.com/m/news/2664383605?lang=zh_CN&edition=full","pubTime":"2026-09-04 10:02","market":"hk","language":"zh","title":"康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383605","media":"新浪港股","summary":"9月4日，$康方生物$盘中涨超8%。9月3日，康方生物宣布，依沃西单抗头对头对比$K$药一线治疗PD-L1阳性晚期非小细胞肺癌的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头对比PD-1/L1疗法的全球Ⅲ期临床中，取得OS和PFS双阳性结果，未来有望凭借更优疗效撬动既有市场格局。","content":"<html><head></head><body><p style=\"text-align: left;\">9月4日，<a href=\"https://laohu8.com/S/09926\">康方生物</a>盘中涨超8%。截至发稿，股价上涨8.04%，现报98.1港元，成交额15亿港元。</p><p style=\"text-align: left;\">此外，诺诚健华升逾2%，和黄医药、四环医药、翰森制药升近2%。</p><p style=\"text-align: left;\">9月3日，康方生物宣布，依沃西单抗头对头对比<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>药一线治疗PD-L1阳性（TPS≥1%）晚期非小细胞肺癌（NSCLC）的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头对比PD-1/L1疗法的全球Ⅲ期临床中，取得OS和PFS双阳性结果，未来有望凭借更优疗效撬动既有市场格局。</p><p style=\"text-align: left;\">公开资料显示，帕博利珠单抗是开启肿瘤免疫治疗1.0时代最具代表性的药物，推动了肺癌治疗的重大进步，成为全球商业化最成功的创新药物之一。在帕博利珠单抗的基础上，依沃西进一步让患者实现显著获益，展现了依沃西作为下一代肿瘤免疫基石药物的突破性临床价值和巨大商业化价值潜力。</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/09e454814ff665aeb70cdb70bfdecf5e\" data-align=\"center\" tg-width=\"973\" tg-height=\"602\"/><span></span></p></body></html>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康方生物盘中涨超8% 康方生物依沃西与K药头对头研究获显著阳性结果\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-04 10:02 北京时间 <a href=https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4027860.shtml><strong>新浪港股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月4日，康方生物盘中涨超8%。截至发稿，股价上涨8.04%，现报98.1港元，成交额15亿港元。此外，诺诚健华升逾2%，和黄医药、四环医药、翰森制药升近2%。9月3日，康方生物宣布，依沃西单抗头对头对比K药一线治疗PD-L1阳性（TPS≥1%）晚期非小细胞肺癌（NSCLC）的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4027860.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{},"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4027860.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2664383605","content_text":"9月4日，康方生物盘中涨超8%。截至发稿，股价上涨8.04%，现报98.1港元，成交额15亿港元。此外，诺诚健华升逾2%，和黄医药、四环医药、翰森制药升近2%。9月3日，康方生物宣布，依沃西单抗头对头对比K药一线治疗PD-L1阳性（TPS≥1%）晚期非小细胞肺癌（NSCLC）的三期临床HARMONi-2达到OS关键次要终点，取得具有统计学显著性和临床获益的阳性结果。截至目前，依沃西已在多项头对头对比PD-1/L1疗法的全球Ⅲ期临床中，取得OS和PFS双阳性结果，未来有望凭借更优疗效撬动既有市场格局。公开资料显示，帕博利珠单抗是开启肿瘤免疫治疗1.0时代最具代表性的药物，推动了肺癌治疗的重大进步，成为全球商业化最成功的创新药物之一。在帕博利珠单抗的基础上，依沃西进一步让患者实现显著获益，展现了依沃西作为下一代肿瘤免疫基石药物的突破性临床价值和巨大商业化价值潜力。","news_type":1,"symbols_score_info":{"09926":2.1,"KURE":0.6}},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
